Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Mar;18(1):210158.
doi: 10.1183/20734735.0158-2021. Epub 2021 Mar 8.

How COVID-19 interacts with interstitial lung disease

Katherine J Myall  1 , Jennifer L Martinovic  1 , Alex West  1
Affiliations
Review

How COVID-19 interacts with interstitial lung disease

Katherine J Myall et al. Breathe (Sheff). 2022 Mar.

Abstract

The global pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has had far-reaching impacts on patients with interstitial lung disease (ILD), from diagnosis to management. In addition, after infection, persistent parenchymal change is associated with ongoing symptoms and functional impairment even in patients without pre-existing lung disease. The challenge of investigating and treating these patients has often fallen to ILD physicians. This review therefore seeks to explore the relationship between COVID-19 and the interstitium, as well as the model of care for patients with pre-existing ILD and those patients with persistent disease following recovery from their initial infection.

Educational aims: To understand the impact of the COVID-19 pandemic on patients with existing interstitial lung disease.To explore the development of interstitial lung disease after COVID-19 infection.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: The authors have nothing to disclose.

References

    1. Portnoy J, Waller M, Elliott T. Telemedicine in the era of COVID-19. J Allergy Clin Immunol 2020; 8: 1489–1491. doi:10.1016/j.jaip.2020.03.008 - DOI - PMC - PubMed
    1. Russell AM, Adamali H, Molyneaux PL, et al. . Daily home spirometry: an effective tool for detecting progression in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2016; 194: 989–997. doi:10.1164/rccm.201511-2152OC - DOI - PMC - PubMed
    1. Wong AW, Fidler L, Marcoux V, et al. . Practical considerations for the diagnosis and treatment of fibrotic interstitial lung disease during the coronavirus disease 2019 pandemic. Chest 2020; 158: 1069–1078. doi:10.1016/j.chest.2020.04.019 - DOI - PMC - PubMed
    1. Gao Y, Chen Y, Liu M, et al. . Impacts of immunosuppression and immunodeficiency on COVID-19: a systematic review and meta-analysis. J Infect 2020; 81: e93–e95. doi:10.1016/j.jinf.2020.05.017 - DOI - PMC - PubMed
    1. Visca D, Mori L, Tsipouri V, et al. . Effect of ambulatory oxygen on quality of life for patients with fibrotic lung disease (AmbOx): a prospective, open-label, mixed-method, crossover randomised controlled trial. Lancet Respir Med 2018; 6: 759–770. doi:10.1016/S2213-2600(18)30289-3 - DOI - PubMed

LinkOut - more resources